[HTML][HTML] 3D approaches to model the tumor microenvironment of pancreatic cancer

E Tomás-Bort, M Kieler, S Sharma, JB Candido… - Theranostics, 2020 - ncbi.nlm.nih.gov
In tumor engineering, 3D approaches are used to model components of the tumor
microenvironment and to test new treatments. Pancreatic cancers are a cancer of substantial …

Theranostics targeting fibroblast activation protein in the tumor stroma: 64Cu-and 225Ac-labeled FAPI-04 in pancreatic cancer xenograft mouse models

T Watabe, Y Liu, K Kaneda-Nakashima… - Journal of Nuclear …, 2020 - Soc Nuclear Med
Fibroblast activation protein (FAP), which promotes tumor growth and progression, is
overexpressed in cancer-associated fibroblasts of many human epithelial cancers. Because …

Molecular regulatory roles of long non-coding RNA HOTTIP: an overview in gastrointestinal cancers

UZ Hamid, MS Sim, RM Guad… - Current molecular …, 2022 - ingentaconnect.com
Gastrointestinal (GI) cancers presented an alarmingly high number of new cancer cases
worldwide and are highly characterised by poor prognosis. The poor overall survival is …

[HTML][HTML] Comprehensive transcriptomic analysis of cell lines as models of primary tumors across 22 tumor types

K Yu, B Chen, D Aran, J Charalel, C Yau… - Nature …, 2019 - nature.com
Cancer cell lines are a cornerstone of cancer research but previous studies have shown that
not all cell lines are equal in their ability to model primary tumors. Here we present a …

Surface Engineering of Natural Killer Cells with CD44‐targeting Ligands for Augmented Cancer Immunotherapy

S Kim, S Li, AK Jangid, HW Park, DJ Lee, HS Jung… - Small, 2024 - Wiley Online Library
Adoptive immunotherapy utilizing natural killer (NK) cells has demonstrated remarkable
efficacy in treating hematologic malignancies. However, its clinical intervention for solid …

pH-sensitive nanodrug carriers for codelivery of ERK inhibitor and gemcitabine enhance the inhibition of tumor growth in pancreatic cancer

P Ray, D Dutta, I Haque, G Nair… - Molecular …, 2020 - ACS Publications
Pancreatic ductal adenocarcinoma (PDAC), a metabolic disorder, remains one of the
leading cancer mortality sources worldwide. An initial response to treatments, such as …

Critical parameters to improve pancreatic cancer treatment using magnetic hyperthermia: Field conditions, immune response, and particle biodistribution

L Beola, V Grazú, Y Fernández-Afonso… - … Applied Materials & …, 2021 - ACS Publications
Magnetic hyperthermia (MH) was used to treat a murine model of pancreatic cancer. This
type of cancer is generally characterized by the presence of dense stroma that acts as a …

Continued exploration of 1, 2, 4-oxadiazole periphery for carbonic anhydrase-targeting primary arene sulfonamides: Discovery of subnanomolar inhibitors of …

M Krasavin, A Shetnev, T Sharonova, S Baykov… - European Journal of …, 2019 - Elsevier
An expanded set of diversely substituted 1, 2, 4-oxadiazole-containing primary aromatic
sulfonamides was synthesized and tested for inhibition of human carbonic anhydrase I, II, IX …

Quantitative monitoring of circulating tumor DNA in patients with advanced pancreatic cancer undergoing chemotherapy

M Sugimori, K Sugimori, H Tsuchiya, Y Suzuki… - Cancer …, 2020 - Wiley Online Library
According to cancer genome sequences, more than 90% of cases of pancreatic ductal
adenocarcinoma (PDAC) harbor active KRAS mutations. Digital PCR (dPCR) enables …

[HTML][HTML] Gene expression comparison between the lymph node-positive and-negative reveals a peculiar immune microenvironment signature and a theranostic role …

A Argentiero, S De Summa, R Di Fonte, RM Iacobazzi… - Cancers, 2019 - mdpi.com
Over the past several years there has been much debate with regards to the prognostic and
clinical significance of pancreatic ductal adenocarcinoma (PDAC) with lymph nodes …